Hospital plans to stop risky drugs often changed during real-world rollout

Hospitals want to stop giving fluoroquinolones to prevent dangerous Clostridioides difficile infections. These drugs can cause severe gut issues. But getting the right plan to work is hard. A review looked at how four different hospital sites tried to put new rules in place. They planned 330 changes to their approach. Most of these changes were planned ahead of time. Only 157 changes happened unexpectedly. This shows that sticking to a plan is difficult in real life. Rural and community hospitals needed more unexpected adjustments than big academic centers. Sites that had tried similar rules before did better. They had fewer surprises when implementing the new safety measures. The review also noted that how hospitals pick their strategies matters. One size does not fit all. Each hospital has unique needs. The study found that context-specific choices are vital. Without them, standard plans fail. This review highlights the gap between theory and practice. Real-world rollout is messy. It requires careful attention to local differences.